Symbol="AXSM"
AssetType="Common Stock"
Name="Axsome Therapeutics Inc"
Description="Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United States. The company is headquartered in New York, New York."
CIK="1579428"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="22 CORTLANDT STREET, 16TH FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3826718000"
EBITDA="-159526384"
PERatio="None"
PEGRatio="0"
BookValue="5.97"
DividendPerShare="0"
DividendYield="0"
EPS="-4.26"
RevenuePerShareTTM="4.234"
ProfitMargin="-1.011"
OperatingMarginTTM="-0.888"
ReturnOnAssetsTTM="-0.256"
ReturnOnEquityTTM="-1.255"
RevenueTTM="182493000"
GrossProfitTTM="45939500"
DilutedEPSTTM="-4.26"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="4.295"
AnalystTargetPrice="116.45"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="134.76"
PriceToBookRatio="20.66"
EVToRevenue="121.47"
EVToEBITDA="-20.98"
Beta="1.878"
num_52WeekHigh="91.29"
num_52WeekLow="38.87"
num_50DayMovingAverage="75.22"
num_200DayMovingAverage="70.66"
SharesOutstanding="47191000"
DividendDate="None"
ExDividendDate="None"
symbol="AXSM"
open="79.99"
high="81.60"
low="79.51"
price="80.80"
volume="554291.00"
latest_trading_day="2023-08-31"
previous_close="79.66"
change="1.14"
change_percent="1.4311%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="22"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="78"
Volume_recent_avg="851265"
Change_recent_avg="0.09"
Delta_recent_avg="3.09"
Variance_recent_avg="1.55"
Change_ratio_recent_avg="0.11"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="78"
Aroon_momentum_negative="22"
image_negative_thumbnail_id_1="506"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0099.jpeg"
image_negative_thumbnail_id_2="495"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0110.jpeg"
image_neutral_thumbnail_id_1="577"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0022.jpeg"
image_neutral_thumbnail_id_2="522"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0077.jpeg"
image_positive_thumbnail_id_1="957"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0119.jpeg"
image_positive_thumbnail_id_2="650"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0058.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
